A class action lawsuit was filed against GeneDx Holdings on July 7, alleging misrepresentations regarding acquisition performance. The company's stock experienced a 49% decline during the period from April 2025 to May 2026. The lawsuit was filed by Bronstein, Gewirtz & Grossman, LLC, accusing the company of violating federal securities laws. The deadline for investors to apply for lead plaintiff status is August 3, 2026.
GeneDx Holdings Corp faces allegations of misleading investors regarding acquisition performance, triggering a massive collapse in share value.
Read the full storyRoblox and GeneDx are facing legal action from Bronstein, Gewirtz & Grossman for allegedly violating federal securities laws and causing investor losses.
GeneDx Holdings faces a class action lawsuit alleging misrepresentations about acquisition performance that led to a 49% share price decline.